Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Net Cash Flow (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Net Cash Flow data on record, last reported at -$6.7 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 247.83% year-over-year to -$6.7 million; the TTM value through Oct 2025 reached -$15.6 million, down 298.29%, while the annual FY2025 figure was -$8.7 million, 171.5% down from the prior year.
  • Net Cash Flow reached -$6.7 million in Q4 2025 per KEQU's latest filing, down from $3.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $15.0 million in Q3 2022 and bottomed at -$17.1 million in Q1 2025.
  • Average Net Cash Flow over 5 years is $404150.0, with a median of $24500.0 recorded in 2021.
  • The widest YoY moves for Net Cash Flow: up 6361.51% in 2022, down 5305.26% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at $95000.0 in 2021, then crashed by 5305.26% to -$4.9 million in 2022, then skyrocketed by 105.34% to $264000.0 in 2023, then skyrocketed by 1613.64% to $4.5 million in 2024, then plummeted by 247.83% to -$6.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$6.7 million in Q4 2025, $3.6 million in Q3 2025, and $4.6 million in Q2 2025.